Genfit S.A. (ADR)
General ticker "GNFT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $194.4M (TTM average)
Genfit S.A. (ADR) follows the US Stock Market performance with the rate: 23.8%.
Estimated limits based on current volatility of 4.3%: low 4.91$, high 5.35$
Factors to consider:
- Total employees count: 194 as of 2019
Short-term GNFT quotes
Long-term GNFT plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €20.20MM | €28.57MM | €67.00MM |
| Operating Expenses | €47.48MM | €55.15MM | €63.72MM |
| Operating Income | €-27.29MM | €-26.58MM | €3.28MM |
| Non-Operating Income | €3.45MM | €-1.93MM | €-1.43MM |
| Interest Expense | €4.41MM | €4.65MM | €4.78MM |
| R&D Expense | €35.82MM | €46.71MM | €47.21MM |
| Income(Loss) | €-23.84MM | €-28.51MM | €1.85MM |
| Taxes | €-0.12MM | €0.38MM | €0.34MM |
| Profit(Loss)* | €-23.72MM | €-28.89MM | €1.51MM |
| Stockholders Equity | €94.53MM | €67.95MM | €69.22MM |
| Inventory | €0.00MM | €0.00MM | €0.00MM |
| Assets | €215.54MM | €173.87MM | €151.42MM |
| Operating Cash Flow | €-72.64MM | €-55.43MM | €15.55MM |
| Capital expenditure | €0.00MM | €2.49MM | €0.98MM |
| Investing Cash Flow | €-46.27MM | €2.23MM | €-1.04MM |
| Financing Cash Flow | €-3.79MM | €-5.10MM | €-10.57MM |
| Earnings Per Share** | €-0.48 | €-0.58 | €0.03 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.